@article{article, title  = {{Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial}},

 url = {{http://eprints.whiterose.ac.uk/110675/ }},

 year = {{2017}},

 month = {{1}},

 author = {{Parker C and Zhan L and Cislo P and Reuning-Scherer J and Vogelzang NJ and Nilsson S and Sartor O and O'Sullivan JM and Coleman RE}},

 doi = {{10.1016/j.ejca.2016.10.020}},

 volume = {{71}},

 journal = {{European Journal of Cancer}},

 pages = {{1-6}},

 note = {{Accessed on 2025/10/10}}}